representative work

Cassels Represents the Underwriters in Khiron’s $28.75 Million Bought Deal Financing


Team: Florence Lau

On May 28, 2019, Khiron Life Sciences Corp. completed a bought deal short form prospectus offering of common shares, including the exercise in full of the over-allotment option. A total of 9,914,150 shares were sold at a price of $2.90 per share for aggregate gross proceeds of approximately $28.75 million.

The offering was completed by a syndicate of underwriters co-led by joint bookrunners Canaccord Genuity Corp. and BMO Capital Markets, and including AltaCorp Capital Inc. and Scotia Capital Inc.

Cassels acted for the underwriters with a deal team that included Nancy Choi and Florence Lau (Securities and Cannabis) and Chris Norton (Tax).


RELATED EXPERTISE: Cannabis | Securities | Taxation